TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.50$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement GNLX
Line item 2019 2020 2021 2022 2023 2024 2025
-98.5% -95.3% +0.0%
+37.9% +36.0% +8.2% +5.2% -11.3% -36.4%
-108.4%
-17.3% +1.5% +43.7% +40.6% +48.8% +4.5%
+98.0% +33.9% -39.7% +131.2% +9.8% +5.2%
+8.2% +16.6% -4.4% +77.8% +32.1% +6.0%
+60.4% +48.6% -22.4% +182.2% -100.0%
+16.1% -22.4% -22.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?